Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
What Might FDA Do Post Roe? Eliminate Mifepristone REMS
Aug 12 2022
•
By
Brenda Sandburg
Biden Administration is considering ways to increase access to the medication abortion pill mifepristone • Source: Shutterstock
More from US FDA
More from Agency Leadership